SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas.

Academic Article
Publication Date:
2007
Iris type:
01.01 Articolo in rivista
List of contributors:
Authors of the University:
Handle:
https://iris.cnr.it/handle/20.500.14243/51111
Published in:
CLINICAL CANCER RESEARCH (PRINT)
Journal